0001881431-21-000001.txt : 20210902 0001881431-21-000001.hdr.sgml : 20210902 20210902173023 ACCESSION NUMBER: 0001881431-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 EFFECTIVENESS DATE: 20210902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aarvik Therapeutics, Inc. CENTRAL INDEX KEY: 0001881431 IRS NUMBER: 852895031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-412250 FILM NUMBER: 211234284 BUSINESS ADDRESS: STREET 1: 34191 TUPELO STREET CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 650 703-2498 MAIL ADDRESS: STREET 1: 34191 TUPELO STREET CITY: FREMONT STATE: CA ZIP: 94555 D 1 primary_doc.xml X0708 D LIVE 0001881431 Aarvik Therapeutics, Inc. 34391 TUPELO STREET FREMONT CA CALIFORNIA 94555 650 703-2498 DELAWARE Aarkus Therapeutics Inc. None Corporation true 2020 Jagath Reddy Junutula c/o Aarvik Therapeutics, Inc. 34391 Tupelo Street Fremont CA CALIFORNIA 94555 Executive Officer Director Anula Jayasuriya c/o Aarvik Therapeutics, Inc. 34391 Tupelo Street Fremont CA CALIFORNIA 94555 Director Richard Scheller c/o Aarvik Therapeutics, Inc. 34391 Tupelo Street Fremont CA CALIFORNIA 94555 Director Pharmaceuticals Decline to Disclose 06b false 2021-08-18 false true false 0 8333333 8333333 0 true 10 112 0 0 500000 true false Aarvik Therapeutics, Inc. Jagath Reddy Junutula Jagath Reddy Junutula Chief Executive Officer 2021-09-02